Sort   by:  
 Page size 

BACKGROUND: One-third of inflammatory bowel disease (IBD) patients show no response to infliximab (IFX) induction therapy, and approximately half of patients responding become unresponsive over time. Thus, identification of potential treatment response biomarkers are of great cl...

2022-01-13 | MTBLS239 | MetaboLights
This dataset includes 2 pairs of tumour/normal whole genome sequence data as well as MEN1 gene targeted sequencing of an additional 87 specimens.
Oncocytic thyroid carcinoma, also known as Hürthle cell thyroid carcinoma, accounts for only a small percentage of all thyroid cancers. However, this malignancy often presents at an advanced stage and poses unique challenges to patients and clinicians. Surgical resection of the tumor accompanied in...
Mutational landscapes of primary triple negative breast cancers - WGS
Mutational landscapes of primary triple negative breast cancers - RNA seq
tumour samples using Affymetrix Genome-Wide SNP6.0 arrays
Mutational landscapes of primary triple negative breast cancers - Exomes
Primary triple negative breast cancers (TNBC) represent approximately 16% of all breast cancers and are a tumour type defined by exclusion,for which comprehensive landscapes of somatic mutation have not been determined. Here we show in 104 early TNBC cases, that at the time of diagnosis these cancer...
RNA sequencing data for 170 medulloblastoma tumor samples
WGS data of medulloblastoma tumor/control pairs.
Sort   by:  
 Page size